Trial intelligence / Profile preview

Danzhijiangtang capsule for vascular lesions in type 2 diabetes

ChiCTR-TRC-13003533Phase 4Completed

Sponsor
First Affiliated Hospital of Anhui University of Chinese Medicine
Start
Jan 2012
Modality
Small Molecules, Implantable Devices → Device-based Delivery → Drug Delivery Systems, Transdermal Patches → Device-based Delivery → Drug Delivery Systems
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of danzhi jiangtang capsule in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by First Affiliated Hospital of Anhui University of Chinese Medicine. Primary endpoint: Carotid intima-media thickness. Started Jan 2012; status: completed.

02

Drugs

danzhi jiangtang capsule
03

Conditions

type 2 diabetes mellitus (T2DM)

Beyond the preview

Go deeper on ChiCTR-TRC-13003533.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR-TRC-13003533.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call